Embecta EMBC
NASDAQ EMBC
$6.74 -0.12 (-1.68%)
As of: Oct 23, 2026 · 2:53 PM EDT

Embecta (EMBC) Asset Writedowns and Impairment (2020 - 2026)

Updated

Embecta's Asset Writedowns and Impairment was $500,000 in fiscal Q2 2026 (quarter ended Mar 31, 2026).

Analysis

Embecta (EMBC) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Asset Writedowns and Impairment at Embecta came in at $10.6 million.

  • Asset Writedowns and Impairment shows a four-year compound annual growth rate of -6.4% (FY2021 to FY2025).
  • In earlier fiscal years, Asset Writedowns and Impairment was $2.5 million in FY2023 (-95.8%), $58.9 million in FY2022 (+326.8%) and $13.8 million in FY2021.
  • The fiscal Q2 2026 figure marks the highest quarterly Asset Writedowns and Impairment since fiscal Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.15 Bn 228.18 Bn 4.88 Bn
2 Abbott Laboratories 179.90 Bn 150.33 Bn 7.27 Bn
3 Danaher 160.18 Bn 143.99 Bn 3.61 Bn
4 Intuitive Surgical 157.81 Bn 138.10 Bn 2.08 Bn
5 Medtronic 122.78 Bn 88.03 Bn 6.34 Bn
6 Stryker 118.11 Bn 104.22 Bn 4.50 Bn
7 Boston Scientific 66.84 Bn 61.61 Bn 3.85 Bn
8 Becton Dickinson 54.72 Bn 51.87 Bn 2.32 Bn
9 Edwards Lifesciences 51.69 Bn 35.69 Bn 1.35 Bn
10 Embecta 394.73 Mn -431.67 Mn 153.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 500,000.00
Jun 30, 2025 200,000.00
Dec 31, 2024 10.40 Mn
Sep 30, 2022 58.90 Mn
Jun 30, 2021 3.80 Mn
Dec 31, 2020 10.00 Mn
API Access

Embecta Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=EMBC&period=max&api_key=YOUR_API_KEY